Cencora price target raised to $274 from $251 at Wells Fargo
Wells Fargo raised the firm’s price target on Cencora (COR) to $274 from $251 and keeps an Equal Weight rating on the shares. The firm is ...
Cencora Inc. stock underperforms Wednesday when compared to competitors
Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...
Barchart on MSN2d
Is Cencora Stock Outperforming the Nasdaq?
With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions ...
Cencora, Inc. (COR): Among Stocks With At Least $30 Million In Insider Sales Recently
We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...
Cencora (NYSE:COR) Eyes Acquisitions and Technology Investments with Potential OneOncology Buyout
Cencora (NYSE:COR) has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.
Best Biotech Stocks To Watch Now – March 12th
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
Here's Why Cencora (COR) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cencora: Higher Potential Returns After Reduced Walgreens Stake
Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging ...
Cencora Inc. stock outperforms competitors on strong trading day
Shares of Cencora Inc. COR advanced 1.82% to $253.54 Friday, on what proved to be an all-around favorable trading session for ...